Technical Analysis for XLRN - Acceleron Pharma Inc.

Grade Last Price % Change Price Change
grade F 41.92 -2.08% -0.89
XLRN closed down 2.08 percent on Thursday, January 17, 2019, on 1.83 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical XLRN trend table...

Date Alert Name Type % Chg
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Down 3 Days in a Row Weakness 0.00%
Jan 17 Down 4 Days in a Row Weakness 0.00%
Jan 17 Down 5 Days in a Row Weakness 0.00%
Jan 16 Fell Below 20 DMA Bearish -2.08%
Jan 16 Volume Surge Other -2.08%
Jan 16 Down 3 Days in a Row Weakness -2.08%
Jan 16 Down 4 Days in a Row Weakness -2.08%
Jan 15 Fell Below 200 DMA Bearish -4.55%
Jan 15 20 DMA Support Bullish -4.55%

Older signals for XLRN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. The company develops sotatercept and ACE-536 that are in Phase II clinical trials to treat anemia and associated complications in patients with ß-thalassemia and myelodysplastic syndromes (MDS), and red blood cell disorders; and dalantercept, which is in Phase II clinical trials to inhibit blood vessel formation in tumors through the vascular endothelial growth factor pathway inhibitors. It has collaboration, license, and option agreement with Celgene Corporation. The company, formerly known as Phoenix Pharma, Inc., was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Is XLRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 59.59
52 Week Low 32.53
Average Volume 479,228
200-Day Moving Average 45.1664
50-Day Moving Average 47.9104
20-Day Moving Average 43.6945
10-Day Moving Average 45.072
Average True Range 2.6679
ADX 17.51
+DI 16.4726
-DI 24.573
Chandelier Exit (Long, 3 ATRs ) 40.5663
Chandelier Exit (Short, 3 ATRs ) 47.9737
Upper Bollinger Band 48.3381
Lower Bollinger Band 39.0509
Percent B (%b) 0.31
BandWidth 21.254849
MACD Line -0.7997
MACD Signal Line -0.9079
MACD Histogram 0.1082
Fundamentals Value
Market Cap 1.62 Billion
Num Shares 38.6 Million
EPS -2.49
Price-to-Earnings (P/E) Ratio -16.84
Price-to-Sales 108.28
Price-to-Book 7.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.70
Resistance 3 (R3) 44.72 43.83 44.23
Resistance 2 (R2) 43.83 43.12 43.81 44.08
Resistance 1 (R1) 42.87 42.68 42.43 42.85 43.92
Pivot Point 41.98 41.98 41.75 41.96 41.98
Support 1 (S1) 41.02 41.27 40.58 41.00 39.92
Support 2 (S2) 40.13 40.83 40.11 39.76
Support 3 (S3) 39.17 40.13 39.61
Support 4 (S4) 39.15